The unearthing study, titled “The nonpsychoactive cannabis constituent cannabidiol is an oral anti-arthritic therapeutic in murine collagen-induced arthritis” was received for review on March 10th, 2000, approved June 2nd, 2000 and published August 15th, 2000(1). This study highlighted the practice of CBD intake (both via injection and orally) to treat murine collagen-induced arthritis (CIA) to some degree.
The results of the study found that CBD stopped the progression of this arthritis through several ways; one of the ways being cannabinoids protecting the joints against serious ongoing damage. Arthritis affects the joints heavily, so this finding is extremely vital to the possibility of CBD becoming a routine remedy for a condition that over 3 million people in the US deal with yearly.
Another way CBD halted the advancement of the arthritis is by blocking the lipopolysaccharide-induced rise in the serum tumor factor. This is what jumps out to us – the cannabinoids combating harmful components on this level is what makes it such a breakthrough in the current wellness field.
The dosages used to stimulate optimal effects in reference to the benefits were 5mg/kg per day by injection or 25mg/kg per day orally. We recommend you get professional medical guidance on which method is safe and appropriate for you and your unique condition.
We are committed to shining more and more light on the topic of CBD, studies concerning cannabinoids and the medical trials of cannabis in entirety, so we thank you all for riding this wave with us!